3.05
Schlusskurs vom Vortag:
$2.84
Offen:
$2.84
24-Stunden-Volumen:
678.12K
Relative Volume:
0.83
Marktkapitalisierung:
$252.68M
Einnahmen:
$70.14M
Nettoeinkommen (Verlust:
$-76.24M
KGV:
-2.7477
EPS:
-1.11
Netto-Cashflow:
$-57.06M
1W Leistung:
+8.54%
1M Leistung:
+33.19%
6M Leistung:
-37.37%
1J Leistung:
-17.12%
Codexis Inc Stock (CDXS) Company Profile
Firmenname
Codexis Inc
Sektor
Branche
Telefon
650-421-8100
Adresse
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Vergleichen Sie CDXS mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
CDXS
Codexis Inc
|
3.05 | 232.79M | 70.14M | -76.24M | -57.06M | -1.11 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-08-19 | Herabstufung | The Benchmark Company | Buy → Hold |
2024-06-03 | Fortgesetzt | Jefferies | Buy |
2024-05-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
2024-02-29 | Hochstufung | The Benchmark Company | Hold → Buy |
2023-11-07 | Herabstufung | The Benchmark Company | Buy → Hold |
2023-08-07 | Herabstufung | TD Cowen | Outperform → Market Perform |
2023-05-09 | Herabstufung | H.C. Wainwright | Buy → Neutral |
2022-03-31 | Fortgesetzt | Piper Sandler | Overweight |
2022-03-02 | Fortgesetzt | Cowen | Outperform |
2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
2021-03-01 | Eingeleitet | Stifel | Buy |
2021-02-26 | Bestätigt | H.C. Wainwright | Buy |
2020-03-10 | Eingeleitet | The Benchmark Company | Buy |
2019-01-17 | Hochstufung | First Analysis Sec | Neutral → Outperform |
2018-05-16 | Eingeleitet | Stephens | Overweight |
2017-10-13 | Bestätigt | H.C. Wainwright | Buy |
2017-05-31 | Eingeleitet | Jefferies | Buy |
2017-01-26 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
2017-01-04 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
2016-01-06 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Codexis Inc Aktie (CDXS) Neueste Nachrichten
Major Shareholder Makes Bold Move with Codexis Stock Purchase - TipRanks
Enzymatic Solutions Leader Codexis Reveals Growth Strategy at Jefferies Healthcare Conference - Stock Titan
What analysts say about Codexis Inc. stockHigh-return market picks - Autocar Professional
Is Codexis Inc. a good long term investmentDynamic profit expansion - Autocar Professional
What drives Codexis Inc. stock priceExceptional gains - Autocar Professional
Codexis Inc. Stock Analysis and ForecastDynamic profit opportunities - Autocar Professional
What makes Codexis Inc. stock price move sharplyFree Consultation - Newser
How Codexis Inc. stock performs during market volatilityFree Market Analysis Group - Newser
Why Codexis Inc. stock attracts strong analyst attentionTop Performing Stocks - Newser
Biocatalysis And Biocatalyst Market Set for Strong Growth Outlook: Codexis, Amano Enzyme, Biocatalysts - newstrail.com
What You Can Learn From Codexis, Inc.'s (NASDAQ:CDXS) P/S - simplywall.st
With 59% ownership, Codexis, Inc. (NASDAQ:CDXS) boasts of strong institutional backing - Yahoo.co
Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Perspective Therapeutics (CATX) and Codexis (CDXS) - The Globe and Mail
Synthetic Biology Market Key Players AnalysisBota - openPR.com
Codexis, Inc. (NASDAQ:CDXS) Position Increased by Assenagon Asset Management S.A. - Defense World
Opaleye Management Makes a Bold Move with Codexis Stock Purchase! - TipRanks
Millennium Management LLC Has $171,000 Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Bank of America Corp DE Has $364,000 Holdings in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Cantor Fitzgerald Forecasts Codexis FY2026 Earnings - Defense World
Squarepoint Ops LLC Has $253,000 Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Investor Network: Codexis, Inc. to Host Earnings Call - ACCESS Newswire
Two Sigma Investments LP Buys 6,397 Shares of Codexis, Inc. (NASDAQ:CDXS) - Defense World
Codexis at Jefferies Global Healthcare Conference: Enzymatic Synthesis Insights By Investing.com - Investing.com Canada
ProShare Advisors LLC Has $127,000 Stake in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Deutsche Bank AG Raises Holdings in Codexis, Inc. (NASDAQ:CDXS) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $218,000 Stock Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Top 5 Synthetic Biology Public Companies (June 2025) - Securities.io
Opaleye Management Makes a Bold Move with Massive Codexis Stock Purchase - TipRanks
Group One Trading LLC Buys Shares of 15,226 Codexis, Inc. (NASDAQ:CDXS) - Defense World
Codexis, Inc. (NASDAQ:CDXS) Stake Lifted by Northern Trust Corp - Defense World
Codexis’ Landmark Presentations at TIDES USA Highlight - GlobeNewswire
Finanzdaten der Codexis Inc-Aktie (CDXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):